NSUN5 and glioblastoma: Consistently, analysis of the GBM‐TCGA‐540 dataset (Affymetrix U133A mRNA expression profiling) using the R2 Genomics Analysis and Visualization Platform, confirmed that high NSUN5 mRNA levels are strongly associated with poor overall and progression‐free survival in GBM patients (Fig. 1A).